John Poulos
Director/Board Member en FARON PHARMACEUTICALS OY .
Fortuna: 17 370 $ al 31/03/2024
Perfil
Mr. John Poulos is an Independent Non-Executive Director at Faron Pharmaceuticals Oy and a President at GNK Advisors, Inc. He is on the Board of Directors at Memgen, Inc. and Faron Pharmaceuticals Oy.
Mr. Poulos was previously employed as a VP, Head-Business Development & Acquisitions by AbbVie Oy and a Head-Pharmaceutical Licensing & Acquisitions by Abbott Pharmaceutical, Inc. He received his undergraduate degree from Indiana University and an MBA from Indiana University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
FARON PHARMACEUTICALS OY
0.01% | 27/10/2023 | 10 000 ( 0.01% ) | 17 370 $ | 31/03/2024 |
Cargos activos de John Poulos
| Empresas | Cargo | Inicio |
|---|---|---|
| FARON PHARMACEUTICALS OY | Director/Board Member | 16/05/2017 |
Memgen, Inc.
 Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Director/Board Member | 18/11/2020 |
| GNK Advisors, Inc. | President | 01/01/2017 |
Antiguos cargos conocidos de John Poulos.
| Empresas | Cargo | Fin |
|---|---|---|
AbbVie Oy
 AbbVie Oy Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Oy is a Finnish company that manufactures and wholesales pharmaceutical products. The private company is based in Espoo, Finland. | Corporate Officer/Principal | 01/01/2016 |
| Abbott Pharmaceutical, Inc. | Corporate Officer/Principal | 01/01/2012 |
Formación de John Poulos.
| Indiana University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| FARON PHARMACEUTICALS OY | Health Technology |
| Empresas privadas | 4 |
|---|---|
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Health Technology |
| Abbott Pharmaceutical, Inc. | |
AbbVie Oy
AbbVie Oy Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Oy is a Finnish company that manufactures and wholesales pharmaceutical products. The private company is based in Espoo, Finland. | Health Technology |
| GNK Advisors, Inc. |
- Bolsa de valores
- Insiders
- John Poulos
